Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study
Significant anti-spike protein receptor-binding domain (S-RBD) antibody responses have been demonstrated in patients with chronic disorder of consciousness (DOC) completing a COVID-19 vaccine regime with BNT162b2 (Pfizer–BioNTech). We now provide further prospective data on the immunogenicity of the...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Clinics and Practice |
Subjects: | |
Online Access: | https://www.mdpi.com/2039-7283/12/3/37 |